AG Anadolu Group Holding Free Cash Flow Generation Index

Latest as of September 2025: 0.75x

AG Anadolu Group Holding free cash flow generation index. AG Anadolu Group Holding (AGHOL) has a Free Cash Flow Generation Index of 0.75x as of September 2025. Free cash flow of TL26.21 Billion represents 1% of operating cash flow (TL35.17 Billion). Check AGHOL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

0.75x
Free Cash Flow / Operating CF

Free Cash Flow

TL26.21 Billion
TRY

Operating Cash Flow

TL35.17 Billion
TRY

Capital Expenditures

TL8.96 Billion
TRY

Free Cash Flow Generation Index of AG Anadolu Group Holding (2017–2024)

Free cash flow generation index of AG Anadolu Group Holding from 2017 to 2024. Historical FCF Generation Index trend for AG Anadolu Group Holding across 8 annual periods. Explore AGHOL capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

AG Anadolu Group Holding Free Cash Flow Generation Index by Year (2017–2024)

AG Anadolu Group Holding free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for AG Anadolu Group Holding. For the full cash flow conversion analysis, see how efficiently does AG Anadolu Group Holding generate cash.

Year FCG Index Free Cash Flow (TRY) Operating CF Capital Expenditures YoY Change
2024 0.46x TL26.35 Billion TL56.90 Billion TL30.54 Billion ▼ -16.9%
2023 0.56x TL33.66 Billion TL60.38 Billion TL26.73 Billion ▼ -16.8%
2022 0.67x TL15.99 Billion TL23.87 Billion TL7.89 Billion ▼ -3.4%
2021 0.69x TL9.29 Billion TL13.41 Billion TL4.30 Billion ▼ -3.6%
2020 0.72x TL6.85 Billion TL9.53 Billion TL2.68 Billion ▲ +5.3%
2019 0.68x TL4.90 Billion TL7.18 Billion TL2.26 Billion ▲ +21.5%
2018 0.56x TL2.20 Billion TL3.92 Billion TL1.77 Billion ▲ +5.5%
2017 0.53x TL1.09 Billion TL2.04 Billion TL952.57 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).